PQA Seeks Pharmacy and Payer Partners for Adult Immunization Pilots
The Pharmacy Quality Alliance (PQA) seeks interested pharmacy and payer partners to participate in proof-of-concept pilots to implement and test high priority immunization pharmacy measure concepts.
PQA has issued a request for interest (RFI) to gauge interest and willingness to participate in these pilots.
The RFI and pilot process timeline is:
- September 12-October 27: Interested and qualified organizations submit responses. Priority will be given to responses received by October 13.
- September 20: PQA-hosted informational webinar- pilot overview, RFI requirements, and Q&A.
- November 17: Organizations are notified of their selection status
- November 2023-March 2024: Contracting phase for selected organizations
- January 2024: 12-month measurement period scheduled to begin
These pilots are designed to advance pharmacy quality measurement and patient care by evaluating the impact of innovative pharmacy services, gaining a deeper understanding of measure concept feasibility and performance, and assessing value to stakeholders.
This project will pilot the PQA Immunization Status: Adults [Pharmacy] (ISA-PH) quality measure concept in the context of payer-pharmacy partnerships (including but not limited to value-based arrangements).
PQA will seek input from participants regarding the measure concepts’ feasibility, promising practices associated with collecting and reporting required data and calculating measure rates, and interventions shown to be successful in improving measure rates. This information may inform future refinements to measure specifications. The results of this pilot, including lessons learned and promising practices, will be disseminated to support scale, spread and sustainability of innovative pharmacy services.
PQA will host an informational webinar on the request for proposals on Wednesday, September 20 at 12:00 p.m. ET. Register here for the webinar.
This pilot opportunity is funded in part by Johnson & Johnson, Pfizer, and GlaxoSmithKline.
After reviewing the request for interest information, if you would like to be considered for the pilot, please complete the form below for pharmacy or payer, depending on your organization type:
To be considered, RFI submissions must be received by Friday, October 27, 11:59 p.m. ET. Priority will be given to responses received by October 13.